Brice

PAST4FUTURE

A platform in which materials and technologies will be developed to stimulate research with so-called organotypic skin, small pieces of cultured skin. The goal of this project is to widely implement these skin models for better skin research and facilitate the development of novel therapeutics for skin diseases.

The Platform for Alternative Skin Tests for sustainable Future science (PAST4FUTURE) is a consortium led by the Radboudumc. This project is carried out together with partners from the Radboud University, VU University Medical Center, Leiden University Medical Center, Association of Cooperating Burns Centers in the Netherlands, CELLnTEC Advanced Cell Systems AG, and TropIQ Health Sciences.

Contact:

Consortium leader: Dr. Ellen van den Bogaard
Laboratory for Experimental Dermatology
Radboud university medical center Radboud Institute for Molecular Life Sciences
ellen.vandenbogaard@radboudumc.nl

Follow us:

News and Media…..

Unique Joining Forces for Better Research with Human Measurement Models

By linking health research as closely as possible to humans and thus making it more applicable and faster, more and more diseases can be prevented or cured in the long term. It is therefore vital to invest now in the development of “Human┬áMeasurement Models”, according to De Samenwerkende Gezondheidsfondsen. De Samenwerkende Gezondheidsfondsen (SGF) have setContinue reading “Unique Joining Forces for Better Research with Human Measurement Models”

967K Euro grant to develop organoids enabling new research methods for skin disorders

Under the leadership of Ellen van den Bogaard and colleagues of theme Inflammatory diseases, a large consortium is setting up a platform in which materials and technologies will be developed to stimulate research with so-called skin organoids, small pieces of cultured skin. The goal of this is to research the effect of these organoids onContinue reading “967K Euro grant to develop organoids enabling new research methods for skin disorders”

‘Such model will enable fundamental biological studies for a better understanding of the aetiology and pathophysiology of psoriasis and aid in novel therapeutic target identification and drug development studies.’

Exp Dermatol (2018) 27(5):512-519.